Inuvo, Inc.

Name: Inuvo, Inc. standardized financial statements, quarterly
Creator: Listed

INUVNYSECIK 829323IndustrialsFiscal year ends Dec 31

Share this page

Link

Story card, 1080 × 1920

Standardized line items from XBRL company facts, the last twelve quarters. Negative values are in parentheses. A figure marked d is derived from year-to-date figures.

Income statement

Revenue$7.5m, Q2 FY2026

Operating income−$3.0m, Q2 FY2026

Net income−$4.0m, Q2 FY2026

Inuvo, Inc., income statement, quarterly
Line item	Unit	Q3 FY20232023-09-30	Q4 FY20232023-12-31	Q1 FY20242024-03-31	Q2 FY20242024-06-30	Q3 FY20242024-09-30	Q4 FY20242024-12-31	Q1 FY20252025-03-31	Q2 FY20252025-06-30	Q3 FY20252025-09-30	Q4 FY20252025-12-31	Q1 FY20262026-03-31	Q2 FY20262026-06-30
Revenue	$m	24.6	20.8	17.0	18.2	22.4	26.2	26.7	22.7	22.6	14.3	7.9	7.5
Cost of revenue	$m	2.3	2.6	2.1	2.9	2.6	4.4	5.6	5.6	6.0	4.8	4.3	4.2
Gross profit	$m	22.3	18.2	14.9	15.3	19.8	21.8	21.1	17.1	16.6	9.5	3.7	3.3
Selling, general and administrative	$m	not reported	not reported	not reported	not reported	not reported	not reported	not reported	not reported	not reported	not reported	not reported	not reported
Operating income	$m	(1.2)	(2.4)	(2.1)	(1.7)	(1.9)	0.2	(1.8)	(2.0)	(1.7)	(1.2)	(3.9)	(3.0)
Interest expense	$m	not reported	not reported	not reported	not reported	not reported	not reported	not reported	not reported	not reported	not reported	not reported	not reported
Income tax	$m	0.0	(0.0)	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Net income	$m	(1.2)	(2.4)	(2.1)	(1.7)	(2.0)	0.1	(1.3)	(1.5)	(1.7)	(0.6)	1.9	(4.0)
Diluted EPS	$ per share	(0.01)	not reported	(0.02)	(0.01)	(0.15)	not reported	(0.09)	(0.10)	(0.12)	not reported	0.13	(0.27)
Basic EPS	$ per share	(0.01)	not reported	not reported	(0.12)	not reported	not reported	(0.09)	(0.10)	not reported	not reported	0.13	(0.27)

Balance sheet

Cash and equivalents$886.5k, Q2 FY2026

Shareholders' equity$8.3m, Q2 FY2026

Inuvo, Inc., balance sheet, quarterly
Line item	Unit	Q3 FY20232023-09-30	FY20232023-12-31	Q1 FY20242024-03-31	Q2 FY20242024-06-30	Q3 FY20242024-09-30	FY20242024-12-31	Q1 FY20252025-03-31	Q2 FY20252025-06-30	Q3 FY20252025-09-30	FY20252025-12-31	Q1 FY20262026-03-31	Q2 FY20262026-06-30
Cash and equivalents	$m	7.0	not reported	2.0	not reported	not reported	not reported	not reported	not reported	not reported	2.8	not reported	0.9
Current assets	$m	18.1	14.7	12.2	11.1	12.3	15.6	15.3	12.5	14.0	9.2	7.8	7.3
Total assets	$m	36.2	32.4	29.8	28.5	29.0	32.2	31.7	28.7	29.9	24.9	23.2	27.3
Current liabilities	$m	16.4	14.5	13.6	13.9	15.7	17.9	17.5	15.9	18.9	14.3	10.6	12.1
Total liabilities	$m	not reported	not reported	not reported	not reported	not reported	not reported	not reported	not reported	not reported	not reported	not reported	not reported
Long-term debt	$m	not reported	not reported	not reported	not reported	not reported	not reported	not reported	not reported	not reported	not reported	not reported	not reported
Current portion of debt	$m	not reported	not reported	not reported	not reported	not reported	not reported	not reported	not reported	not reported	not reported	not reported	not reported
Shareholders' equity	$m	18.9	17.0	15.1	13.5	12.4	13.5	13.4	12.1	10.4	10.0	12.2	8.3

Cash flow

Operating cash flow−$2.3m, Q2 FY2026

Capital expenditure$239.3k, Q2 FY2026

Inuvo, Inc., cash flow, quarterly
Line item	Unit	Q3 FY20232023-09-30	Q4 FY20232023-12-31	Q1 FY20242024-03-31	Q2 FY20242024-06-30	Q3 FY20242024-09-30	Q4 FY20242024-12-31	Q1 FY20252025-03-31	Q2 FY20252025-06-30	Q3 FY20252025-09-30	Q4 FY20252025-12-31	Q1 FY20262026-03-31	Q2 FY20262026-06-30
Operating cash flow	$k	2,376	(2,096)	(1,356)	195	1,060	330	(367)	144	(1,584)	21.0	1,590	(2,307)
Capital expenditure	$k	423	423	472	462	476	448	452	407	383	361	359	239
Share repurchases	$k	not reported	not reported	not reported	not reported	not reported	not reported	not reported	not reported	not reported	not reported	not reported	not reported

Diluted shares (weighted)14.84m, Q2 FY2026

Inuvo, Inc., shares, quarterly
Line item	Unit	Q3 FY20222022-09-30	Q1 FY20232023-03-31	Q2 FY20232023-06-30	Q3 FY20232023-09-30	Q1 FY20242024-03-31	Q2 FY20242024-06-30	Q3 FY20242024-09-30	Q1 FY20252025-03-31	Q2 FY20252025-06-30	Q3 FY20252025-09-30	Q1 FY20262026-03-31	Q2 FY20262026-06-30
Diluted shares (weighted)	m shares	120	121	127	127	139	14.0	14.0	14.3	14.5	14.6	14.9	14.8

Shares outstanding: 16.48m at Aug 3, 2026, from the cover of the 10-Q filed Aug 11, 2026.

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:25 ET. Listed shows no prices and gives no investment advice.